New York State Common Retirement Fund
CTNM

New York State Common Retirement Fund’s Contineum Therapeutics CTNM Stock Holding History

New York State Common Retirement Fund’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Buy
+9,400
New +$123K ﹤0.01% 2482
2025
Q2 		– Sell
-600
Closed -$4.19K – 3371
2025
Q1 		$4.19K Hold
600
– – ﹤0.01% 3133
2024
Q4 		$8.79K Hold
600
– – ﹤0.01% 3117
2024
Q3 		$11.5K Sell
600
-4,800
-89% -$92K ﹤0.01% 3097
2024
Q2 		$95.1K Buy
+5,400
New +$87K ﹤0.01% 2888

Other funds holding CTNM

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

New York State Common Retirement Fund's CTNM Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Contineum Therapeutics (CTNM) in Q2 2026: 9,400 shares worth $154K. The stake represents ﹤0.01% of the portfolio and ranks #2482 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in CTNM as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in CTNM in Q2 2024 and has held it in 5 quarters since. 102 funds tracked by Wall St. Rank hold CTNM as of Q2 2026.

  • New York State Common Retirement Fund held 9,400 shares of Contineum Therapeutics worth $154K as of Q2 2026.
  • Contineum Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • Contineum Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2482 holding.
  • New York State Common Retirement Fund first reported a position in Contineum Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 102 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.